期刊文献+

康莱特联合沙培林治疗老年恶性胸腔积液的临床观察 被引量:2

Clinical Observation on Kanglaite Combined with Sapylin in the Treatment of Malignant Pleural Effusion Induced by Lung Cancer of the Elderly
下载PDF
导出
摘要 目的观察康莱特联合沙培林治疗老年恶性胸腔积液的近期疗效、生活质量提高情况。方法56例诊断为肺癌恶性胸腔积液的老年患者随机分组,治疗组28例应用康莱特的同时给予沙培林胸腔灌注治疗,对照组28例仅用沙培林胸腔灌注治疗,4周后观察疗效。结果有效率(CR+PR)治疗组为89.3%,对照组为85.7%,治疗组疾病控制率高于对照组,但差异无统计学意义,而治疗组较对照组的生活质量明显提高,差异有统计学意义(P<0.05)。结论康莱特联合沙培林可提高恶性胸腔积液的疗效、改善患者生活质量。 Objective To evaluate the therapeutic effects and the quality of life of Kanglaite combined with Sapylin in the treatment of malig- nant pleural effusion induced by lung cancer of the elderly. Methods 56 elderly patients diagnosed as malignant pleural effusion induced by lung cancer were randomly divided into two groups. The observation group received Kanglaite combined with intrapleural injection of Sapylin, the contrast group was given injection of Sapylin alone. The therapeutic effect was observed after four weeks. Results The effective rate of observation group(89.3% ) was more than that of the contrast group( 85.7% ). While there was no significant difference in the combined group (P 〉 0.05). But observation group at increasing body was superior to those in contrast group and there was significant difference(P 〈 0.05 ). Conclusion Kanglaite combined with Sapylin can impove efficacy and the quality of life in the treatment of malignant pleural effusion.
出处 《肿瘤基础与临床》 2008年第5期413-414,共2页 journal of basic and clinical oncology
关键词 康莱特 沙培林 恶性胸腔积液 生活质量 Kanglaite Sapylin malignant pleural effusion quality of live
  • 相关文献

参考文献4

二级参考文献15

  • 1林兰珠 邱锡谦 蔡友鹏.高聚金葡素配合顺铂治疗恶性胸腔积液临床观察.肿瘤研究与临床,1999,11(1):42-42.
  • 2冯德辉 邓承基.恶性胸腔积液[A].银正民 主编.临床肿瘤急症学[C].北京:人民卫生出版社,2000.370-375.
  • 3[2]Smyth MT,Kershaw MH,Trapani TA.Xenospeicfic cytotoxic T lymphocytes:potent lysis in vitro and in vivo [J].Transplantation,1997,63(8) :1171 ~ 1178.
  • 4[3]Frey AB,Cestari S.Killing of rat adenocarcinoma 13762 in situ by adoptive transfer of CD4 + anti - tumor T cells requires tumor expression of cell surface MHC class Ⅱ molecules[J].Cells- Immunol,1997,178 (1) :5728 ~ 5735.
  • 5[4]Salvadori S,Martinelli G,Zier K.Resection of solid tumor reverses T cell defects and restores protective immunity [J].J Immunol,2000,164(4) :2214 ~ 2220.
  • 6[5]Bronte V,Chappell DB,Apolloni E,et al.Unopposed production of granulocyte - macrophage colony - stimulating factor by tumors inhibits CD8 + T cell responses by dysregulating antigen - presenting cell maturation [J].J Immunol,1999,162 (10):5728 ~5737.
  • 7[1]Miller AB,Hoogstraten B,Stagnet M,et al.Reporting results of cancer treament[J].Cancer,1981,47:207~208.
  • 8Uchida A. 0K-432, a streptococcal preparation as a potent biological response modifier[J]. Int J Cancer, 1983,31(1) :44.
  • 9钱振超 张天泽 徐光炜.溶血性链球菌制剂Ok-432(沙培林)[A].张天泽,徐光炜.肿瘤学[C].天津:天津科学技术出版社,1998.781-782.
  • 10朱亚芳,魏金芝.康莱特治疗恶性肿瘤44例报告[J].肿瘤研究与临床,1998,10(1):43-44. 被引量:21

共引文献69

同被引文献101

引证文献2

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部